Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eyenovia Inc

EYEN
Current price
1.43 USD -0.01 USD (-0.69%)
Last closed 1.42 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 59 564 972 USD
Yield for 12 month -26.85 %
Week
Month
Year
EYEN
21.11.2021 - 28.11.2021

Eyenovia, Inc., a pre-commercial ophthalmic company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. It focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi in rest of Asia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York. Address: 295 Madison Avenue, New York, NY, United States, 10017

Analytics

WallStreet Target Price

11.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+14 000 000 USD

Current Quarter

+1 198 USD

Last Quarter

Current Year

Last Year

+12 400 000 USD

Current Quarter

Last Quarter

Key Figures EYEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -22 727 958 USD
Operating Margin TTM -544255.96 %
PE Ratio
Return On Assets TTM -43.97 %
PEG Ratio
Return On Equity TTM -140.78 %
Wall Street Target Price 11.67 USD
Revenue TTM 1 198 USD
Book Value 0.37 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 400 %
Dividend Yield
Gross Profit TTM 12 400 000 USD
Earnings Share -0.66 USD
Diluted Eps TTM -0.66 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EYEN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EYEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EYEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.5453
Price Sales TTM 6.4156
Enterprise Value EBITDA -3.0908
Price Book MRQ 3.228

Financials EYEN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators EYEN

For 52 weeks

1.05 USD 5.85 USD
50 Day MA 1.42 USD
Shares Short Prior Month 1 654 424
200 Day MA 2.54 USD
Short Ratio 6.91
Shares Short 1 745 158
Short Percent 5.45 %